Literature DB >> 23815625

Caspase-2 is essential for c-Jun transcriptional activation and Bim induction in neuron death.

Ying Y Jean1, Elena M Ribe, Maria Elena Pero, Marina Moskalenko, Zarah Iqbal, Lianna J Marks, Lloyd A Greene, Carol M Troy.   

Abstract

Neuronal apoptotic death generally requires de novo transcription, and activation of the transcription factor c-Jun has been shown to be necessary in multiple neuronal death paradigms. Caspase-2 has been implicated in death of neuronal and non-neuronal cells, but its relationship to transcriptional activation has not been clearly elucidated. In the present study, using two different neuronal apoptotic paradigms, β-amyloid treatment and NGF (nerve growth factor) withdrawal, we examined the hierarchical role of caspase-2 activation in the transcriptional control of neuron death. Both paradigms induce rapid activation of caspase-2 as well as activation of the transcription factor c-Jun and subsequent induction of the pro-apoptotic BH3 (Bcl-homology domain 3)-only protein Bim (Bcl-2-interacting mediator of cell death). Caspase-2 activation is dependent on the adaptor protein RAIDD {RIP (receptor-interacting protein)-associated ICH-1 [ICE (interleukin-1β-converting enzyme)/CED-3 (cell-death determining 3) homologue 1] protein with a death domain}, and both caspase-2 and RAIDD are required for c-Jun activation and Bim induction. The present study thus shows that rapid caspase-2 activation is essential for c-Jun activation and Bim induction in neurons subjected to apoptotic stimuli. This places caspase-2 at an apical position in the apoptotic cascade and demonstrates for the first time that caspase-2 can regulate transcription.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23815625      PMCID: PMC3905453          DOI: 10.1042/BJ20130556

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  60 in total

1.  beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation.

Authors:  C M Troy; S A Rabacchi; Z Xu; A C Maroney; T J Connors; M L Shelanski; L A Greene
Journal:  J Neurochem       Date:  2001-04       Impact factor: 5.372

Review 2.  Caspase-2: the orphan caspase.

Authors:  L Bouchier-Hayes; D R Green
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

3.  A knockout of the caspase 2 gene produces increased resistance of the nigrostriatal dopaminergic pathway to MPTP-induced toxicity.

Authors:  Meenakshi Tiwari; Brian Herman; William W Morgan
Journal:  Exp Neurol       Date:  2011-03-16       Impact factor: 5.330

4.  Genetic inhibition of caspase-2 reduces hypoxic-ischemic and excitotoxic neonatal brain injury.

Authors:  Ylva Carlsson; Leslie Schwendimann; Regina Vontell; Catherine I Rousset; Xiaoyang Wang; Sophie Lebon; Christiane Charriaut-Marlangue; Veena Supramaniam; Henrik Hagberg; Pierre Gressens; Etienne Jacotot
Journal:  Ann Neurol       Date:  2011-06-14       Impact factor: 10.422

5.  The proteolytic procaspase activation network: an in vitro analysis.

Authors:  M Van de Craen; W Declercq; I Van den brande; W Fiers; P Vandenabeele
Journal:  Cell Death Differ       Date:  1999-11       Impact factor: 15.828

Review 6.  The role of bim, a proapoptotic BH3-only member of the Bcl-2 family in cell-death control.

Authors:  A Strasser; H Puthalakath; P Bouillet; D C Huang; L O'Connor; L A O'Reilly; L Cullen; S Cory; J M Adams
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

7.  Caspase-2 mediates neuronal cell death induced by beta-amyloid.

Authors:  C M Troy; S A Rabacchi; W J Friedman; T F Frappier; K Brown; M L Shelanski
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

8.  Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation.

Authors:  T S Zheng; S Hunot; K Kuida; T Momoi; A Srinivasan; D W Nicholson; Y Lazebnik; R A Flavell
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

9.  Ocular neuroprotection by siRNA targeting caspase-2.

Authors:  Z Ahmed; H Kalinski; M Berry; M Almasieh; H Ashush; N Slager; A Brafman; I Spivak; N Prasad; I Mett; E Shalom; E Alpert; A Di Polo; E Feinstein; A Logan
Journal:  Cell Death Dis       Date:  2011-06-16       Impact factor: 8.469

10.  Neuronal caspase 2 activity and function requires RAIDD, but not PIDD.

Authors:  Elena M Ribe; Ying Y Jean; Rebecca L Goldstein; Claudia Manzl; Leonidas Stefanis; Andreas Villunger; Carol M Troy
Journal:  Biochem J       Date:  2012-06-15       Impact factor: 3.857

View more
  9 in total

1.  Nitrosylation of GAPDH augments pathological tau acetylation upon exposure to amyloid-β.

Authors:  Tanusree Sen; Pampa Saha; Nilkantha Sen
Journal:  Sci Signal       Date:  2018-03-20       Impact factor: 8.192

2.  Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus.

Authors:  Ying Y Jean; Jimena Baleriola; Mauro Fà; Ulrich Hengst; Carol M Troy
Journal:  J Vis Exp       Date:  2015-06-17       Impact factor: 1.424

Review 3.  Caspases: therapeutic targets in neurologic disease.

Authors:  Carol M Troy; Ying Y Jean
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 6.088

Review 4.  Programmed cell death during neuronal development: the sympathetic neuron model.

Authors:  M Kristiansen; J Ham
Journal:  Cell Death Differ       Date:  2014-04-25       Impact factor: 15.828

5.  Mutations in CRADD Result in Reduced Caspase-2-Mediated Neuronal Apoptosis and Cause Megalencephaly with a Rare Lissencephaly Variant.

Authors:  Nataliya Di Donato; Ying Y Jean; A Murat Maga; Briana D Krewson; Alison B Shupp; Maria I Avrutsky; Achira Roy; Sarah Collins; Carissa Olds; Rebecca A Willert; Agnieszka M Czaja; Rachel Johnson; Jessi A Stover; Steven Gottlieb; Deborah Bartholdi; Anita Rauch; Amy Goldstein; Victoria Boyd-Kyle; Kimberly A Aldinger; Ghayda M Mirzaa; Anke Nissen; Karlla W Brigatti; Erik G Puffenberger; Kathleen J Millen; Kevin A Strauss; William B Dobyns; Carol M Troy; Robert N Jinks
Journal:  Am J Hum Genet       Date:  2016-10-20       Impact factor: 11.025

6.  Pigment epithelium-derived factor mediates retinal ganglion cell neuroprotection by suppression of caspase-2.

Authors:  Vasanthy Vigneswara; Zubair Ahmed
Journal:  Cell Death Dis       Date:  2019-02-04       Impact factor: 8.469

7.  Genetic and Real-World Clinical Data, Combined with Empirical Validation, Nominate Jak-Stat Signaling as a Target for Alzheimer's Disease Therapeutic Development.

Authors:  Alejo J Nevado-Holgado; Elena Ribe; Laura Thei; Laura Furlong; Miguel-Angel Mayer; Jie Quan; Jill C Richardson; Jonathan Cavanagh; Nima Consortium; Simon Lovestone
Journal:  Cells       Date:  2019-05-08       Impact factor: 6.600

8.  A soluble tau fragment generated by caspase-2 is associated with dementia in Lewy body disease.

Authors:  Benjamin R Smith; Kathryn M Nelson; Lisa J Kemper; Kailee Leinonen-Wright; Ashley Petersen; C Dirk Keene; Karen H Ashe
Journal:  Acta Neuropathol Commun       Date:  2019-07-30       Impact factor: 7.801

9.  Upregulated miRNA-182-5p expression in tumor tissue and peripheral blood samples from patients with non-small cell lung cancer is associated with downregulated Caspase 2 expression.

Authors:  Lu Yang; Ye Dou; Zhuxin Sui; Hui Cheng; Xia Liu; Qinglu Wang; Peifu Gao; Yin'e Qu; Ming Xu
Journal:  Exp Ther Med       Date:  2019-10-02       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.